The Valley Desk

NCT06937086 · Interventional trial

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Overall registry status Recruiting

Phase 3

Conditions Obesity or Overweight, Ulcerative Colitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov